Latest News
AbbVie Completes $10.9B Apogee Buyout, Accretion Delayed to 2032
AbbVie closes its $10.9B Apogee acquisition, projecting EPS dilution until 2032, while strong Skyrizi and Rinvoq growth funds the long-term bet.
Honeywell Aerospace Chair Buys $998K in Stock After 27% Drop
Honeywell Aerospace chair Craig Arnold purchased $998,400 worth of HONA stock after a 27% decline, signaling insider confidence in a turnaround.
Cathay Pacific Extends Middle East Suspension; Fuel Costs Loom Larger
Cathay Pacific extends Middle East flight suspension to Nov 30, yet shares gain 0.6% as investors focus on rising fuel costs rather than route closures.
Trade Desk's Brief S&P 500 Tenure Ends After 82% Plunge
The Trade Desk (TTD) will be removed from the S&P 500 after only 430 days, a period marked by an 82% share price collapse. The company moves to the SmallCap 600 as it grapples with slowing revenue and a workforce reduction.
NSE IPO Gets SEBI Nod: Purely an Offer for Sale, No Fresh Capital
NSE's IPO has cleared SEBI's review. The offer comprises 148.9 million existing shares, with no new capital raised. All proceeds go to selling shareholders.
Bitcoin ETF Inflows Cool 76% as Price Retreats Below $80K
U.S. spot bitcoin ETFs attracted $174.6M on Friday, down 76% from Thursday's surge, as bitcoin fell back under $80,000. IBIT accounted for most inflows, raising sustainability concerns.
TSMC ADR Climbs 2.9% as Fab Expansion Struggles to Keep Pace with AI Boom
TSMC's massive fab buildout still can't match AI demand, says exec. ADR up 2.9% as investors weigh capacity constraints and 2027-28 ramp timelines.
Standard Chartered's UAE Crypto Launch: A Strategic Move Beyond the 1.8% Share Gain
Standard Chartered's UAE crypto trading launch drove shares up 1.8%. The integrated custody, stablecoin, and execution stack is strategic but lacks financial details.
Clorox Recall of 6.3M Cleaners Causes Only Minor Stock Dip
Clorox's massive recall of 6.3 million cleaners barely dented its stock, which fell 1.3%. The limited scope and no reported injuries keep the financial impact uncertain.
Vistra CEO's $903K Buy: A Drop in the Ocean or a Signal?
Vistra's CEO bought $903K in stock near the low, but the trade is a small signal compared to the company's $1.2B buyback and strong cash flow guidance.
Mortgage Rates at 6.71%: The Real Cost of Crossing the 6% Threshold
Freddie Mac's 30-year mortgage rate rose to 6.71%, adding $1,933 a year to the median homebuyer's payment. Housing demand stays stable but faces headwinds.
UiPath Shares Tumble 17% as Guidance Lift Masks Tepid H2 Outlook
UiPath shares fell 16.63% on Friday despite a Q2 revenue beat, as the company's full-year guidance raise adds just $244K to the second-half midpoint.